Elite Pharmaceuticals, Inc. (QB) Stock Price - ELTP

Best deals to access real time data!
Monthly Subscription
for only
DDE w/Realtime (Monthly)
Monthly Subscription
for only
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type ISIN
Elite Pharmaceuticals, Inc. (QB) ELTP Other OTC Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded DELAYED
  -0.006316 -3.17% 0.193 0.1993 0.189 0.1993 0.199316 16:00:00
Bid Price Ask Price Spread Spread % News
0.189 0.193 0.004 2.07% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
88 1,005,010 $ 0.1917 $ 192.69k 1.01M 0.11 - 0.40
Last Trade Time Type Quantity Stock Price Currency
15:58:24 500 $0.19 USD

Elite Pharmaceuticals, Inc. (QB) Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 177.15M 917.9M $ 3.81M - 46.48 593.92M
Short Interest Short % of Out Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
78.08k 0.01% $ - 0.00% - -

more financials information »

Elite Pharmaceuticals, Inc. (QB) News

Date Time Source News Article
6/14/201717:08Edgar (US Regulatory)Current Report Filing (8-k)
6/14/201716:46Edgar (US Regulatory)Annual Report (10-k)
6/06/201706:03Edgar (US Regulatory)Notice of Effectiveness (effect)
6/05/201717:30Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)
6/02/201713:46Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3/a)
5/22/201717:11Edgar (US Regulatory)Current Report Filing (8-k)
5/10/201717:24Edgar (US Regulatory)Small Company Offering and Sale of Securities Without..

Latest ELTP Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ELTP Price Data

Period † Open High Low VWAP Min Vol Max Vol Avg. Daily Vol [m] Change %
1 Week0.187050.2090.1850.0000423k1M694k0.005953.18%
1 Month0.176990.2159210.17350.0000385k2M856k0.016019.05%
3 Months0.146650.24950.1390.0000192k4M1M0.0463531.61%
6 Months0.16720.24950.1250.0000192k5M1M0.025815.43%
1 Year0.30750.3950.110.0000107k20M1M-0.1145-37.24%
3 Years0.44520.45890.110.0000020M1M-0.2522-56.65%
5 Years0.13250.970.00010.0000029M2M0.060545.66%

Elite Pharmaceuticals, Inc. (QB) Description

Elite Pharmaceuticals, Inc. is a specialty pharmaceutical company which is developing a pipeline of proprietary pharmacological abuse-deterrent opioid products as well as niche generic products. Elite specializes in oral sustained and controlled release drug products which have high barriers to entry. Elite owns generic and OTC products which have been licensed to TAGI Pharma, Epic Pharma and Valeant Pharmaceuticals International. Elite currently has eight commercial products being sold, additional approved products pending manufacturing site transfer and the NDA for SequestOx, for which it received the CRL from the FDA. Elite's lead pipeline products include abuse-deterrent opioids which utilize the Company's patented proprietary technology and a once-daily opioid. These products include sustained release oral formulations of opioids for the treatment of chronic pain. These formulations are intended to address two major limitations of existing oral opioids: the provision of consistent relief of baseline pain levels and deterrence of potential opioid abuse. Elite also provides contract manufacturing for Ascend Laboratories (a subsidiary of Alkem Laboratories Ltd.). Elite operates a GMP and DEA registered facility for research, development, and manufacturing located in Northvale, NJ. Learn more at www.elitepharma.com.
Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:30 V: D:20170624 08:38:07